SCHEMBL4459331

SCHEMBL4459331

CC(C)(C)OC(=O)N1CCN(c2ccnc(N)c2N)CC1

nearest known ligand 0.55

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
MAP4K4 O95819 1/20 0.55
SMARCA2 P51531 1/20 0.54
SMARCA4 P51532 1/20 0.54
PBRM1 Q86U86 1/20 0.54
PTPN11 Q06124 1/20 0.50
GPR119 Q8TDV5 6/20 0.49
ACHE P22303 2/20 0.49
POLB P06746 1/20 0.49
CKS1B P61024 2/20 0.48
SKP1 P63208 2/20 0.48
SKP2 Q13309 2/20 0.48
ALDH1A1 P00352 1/20 0.48
LMNA P02545 1/20 0.48
MAPT P10636 1/20 0.48
PIK3CA P42336 1/20 0.47
CHRNA7 P36544 1/20 0.46
KIT P10721 1/20 0.46
ADORA2A P29274 1/20 0.45
ADORA1 P30542 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12517592 0.86 ACHE (0.47) MAP4K4SMARCA2SMARCA4PBRM1PTPN11
SCHEMBL30592004 0.85 POLB (0.57) MAP4K4SMARCA2SMARCA4PBRM1PTPN11
SCHEMBL14206364 0.85 POLB (0.57) MAP4K4SMARCA2SMARCA4PBRM1PTPN11
SCHEMBL4467502 0.84 ALDH1A1 (0.56) MAP4K4SMARCA2SMARCA4PBRM1PTPN11
SCHEMBL12518778 0.82 CKS1B (0.48) MAP4K4SMARCA2SMARCA4PBRM1PTPN11
SCHEMBL1955606 0.80 GPR119 (0.54) MAP4K4SMARCA2SMARCA4PBRM1PTPN11
SCHEMBL1967744 0.80 POLB (0.60) MAP4K4SMARCA2SMARCA4PBRM1GPR119
SCHEMBL30914247 0.80 GPR119 (0.54) MAP4K4SMARCA2SMARCA4PBRM1PTPN11
SCHEMBL31152780 0.80 SMARCA2 (0.55) MAP4K4SMARCA2SMARCA4PBRM1PTPN11
SCHEMBL1249642 0.80 SMARCA2 (0.55) MAP4K4SMARCA2SMARCA4PBRM1PTPN11

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7534796-B2 Imidazo[4,5-b]pyridine antagonists of gonadotropin releasing hormone receptor WYETH (US) 2009-05-19 US disclosed
US-7534796-B2 Imidazo[4,5-b]pyridine antagonists of gonadotropin releasing hormone receptor WYETH (US) 2009-05-19 US disclosed
US-7534796-B2 Imidazo[4,5-b]pyridine antagonists of gonadotropin releasing hormone receptor WYETH (US) 2009-05-19 US disclosed
US-20060189617-A1 Imidazo[4,5-b]pyridine antagonists of gonadotropin releasing hormone receptor WYETH (US) 2006-08-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060189617-A1 Imidazo[4,5-b]pyridine antagonists of gonadotropin releasing hormone receptor GNRHR, PRLHR, FSHR MAP4K4 1192/4885SMARCA2 4774/4885SMARCA4 4634/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.